FDA Sets Outcomes Benchmarks For Actual Use Trials

FDA is providing OTC switch application sponsors with pre-defined benchmarks for actual use trials, Center for Drug Evaluation and Research executive Andrea Leonard-Segal says

More from Archive

More from Pink Sheet